Top Story

Radiation reduces failure risk in newly diagnosed nonmetastatic prostate cancer

December 1, 2015

Routine use of radiation therapy appeared to prolong failure-free survival among patients with nonmetastatic, newly diagnosed prostate cancer regardless of nodal status, according to findings from the control arm of the STAMPEDE trial.

The STAMPEDE trial is a multiarm, multistage study of men with prostate cancer starting first-line hormone therapy. Researchers are evaluating the impact of the addition of treatments to hormone-based therapy. The control arm of the study evaluates the use of hormone therapy with radiotherapy when appropriate — radiation was offered to nonmetastatic patients at the start of the trial, but it became mandatory in November 2011 based on data from other reports.

In the Journals

Higher-dose radiation worsens quality of life among patients with NSCLC

November 30, 2015
Patients with non–small cell lung cancer assigned a higher radiation dose experienced a clinically meaningful decline in quality of life, according to a secondary…

University of California, San Diego, names chair in urology

November 30, 2015
Christopher J. Kane, MD, a prostate cancer specialist and an expert in robotic and other minimally invasive procedures for urologic surgery at University of California…
In the Journals

In-person consults reveal melanomas at an earlier stage

November 30, 2015
Early-stage melanoma was more likely to be detected during an in-person consult than in an incidental fashion, according to study results.Researchers studied records…
FDA News

FDA approves Empliciti for multiple myeloma

November 30, 2015
The FDA today approved elotuzumab in combination with two other therapies for treatment of patients with multiple myeloma who received one to three prior…
More News Headlines »

The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »
Meeting News Coverage Video

HPV vaccination falling short due to providers, not parents

November 22, 2015
More »

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan morganatic-roan